Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michela Boi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
British Journal of Haematology|January 7, 2015
Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomasMichela Boi, Emanuele Zucca, Giorgio Inghirami, et al.
Leukemia & Lymphoma|August 14, 2014
PRDM1/BLIMP1: a tumor suppressor gene in B and T cell lymphomasMichela Boi, Emanuele Zucca, Giorgio Inghirami, et al.
Cancer Science|May 10, 2012
Genetic alterations in systemic nodal and extranodal non-cutaneous lymphomas derived from mature T cells and natural killer cellsMichela Boi, Anastasios Stathis, Emanuele Zucca, et al.
Pest Management Science|October 2, 2015
A 10 year survey of acaricide residues in beeswax analysed in ItalyMichela Boi, Giorgia Serra, Roberto Colombo, et al.
Nature Communications|April 21, 2015
Epigenomic evolution in diffuse large B-cell lymphomasHeng Pan, Yanwen Jiang, Michela Boi, et al.
Oncotarget|October 30, 2016
Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypesMichela Boi, Maria Todaro, Valentina Vurchio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2015
The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted DrugsMichela Boi, Eugenio Gaudio, Paola Bonetti, et al.
Haematologica|December 31, 2011
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genesSimone Ferrero, Daniela Capello, Mirija Svaldi, et al.
Mechanisms of Ageing and Development|June 13, 2012
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartmentChiara Lobetti-Bodoni, Dario Ferrero, Elisa Genuardi, et al.
Blood|September 6, 2013
PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphomaMichela Boi, Andrea Rinaldi, Ivo Kwee, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
British Journal of Haematology|January 7, 2015
Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomasMichela Boi, Emanuele Zucca, Giorgio Inghirami, et al.
Leukemia & Lymphoma|August 14, 2014
PRDM1/BLIMP1: a tumor suppressor gene in B and T cell lymphomasMichela Boi, Emanuele Zucca, Giorgio Inghirami, et al.
Cancer Science|May 10, 2012
Genetic alterations in systemic nodal and extranodal non-cutaneous lymphomas derived from mature T cells and natural killer cellsMichela Boi, Anastasios Stathis, Emanuele Zucca, et al.
Pest Management Science|October 2, 2015
A 10 year survey of acaricide residues in beeswax analysed in ItalyMichela Boi, Giorgia Serra, Roberto Colombo, et al.
Nature Communications|April 21, 2015
Epigenomic evolution in diffuse large B-cell lymphomasHeng Pan, Yanwen Jiang, Michela Boi, et al.
Oncotarget|October 30, 2016
Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypesMichela Boi, Maria Todaro, Valentina Vurchio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2015
The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted DrugsMichela Boi, Eugenio Gaudio, Paola Bonetti, et al.
Haematologica|December 31, 2011
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genesSimone Ferrero, Daniela Capello, Mirija Svaldi, et al.
Mechanisms of Ageing and Development|June 13, 2012
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartmentChiara Lobetti-Bodoni, Dario Ferrero, Elisa Genuardi, et al.
Blood|September 6, 2013
PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphomaMichela Boi, Andrea Rinaldi, Ivo Kwee, et al.
Pageof 2